The State Council ordered: 'convenience store drug sales' nationwide rollout!
On August 28, the General Office of the State Council issued the "Opinions on Accelerating the Development of Circulation to Promote Commercial Consumption" (hereinafter referred to as "Opinions"), which put forward 20 policy measures to stabilize consumption expectations and boost consumer confidence. Among them, it is clearly mentioned to accelerate the development of chain convenience stores, to carry out pilot procedures to simplify the approval of tobacco and Class B non-prescription drug operations. In other words, convenience stores selling drugs, to accelerate the country. According to data from the China Tobacco Industry Association, China has a total of 5 million small supermarkets, department stores, convenience stores, grocery stores and other retail outlets for everyday goods. But there may not be as many, but no less, if you count real convenience stores with modern operations and full services.
According to the latest China Convenience Store Development Report 2019 released by KPMG China and China Chain Store Association, there were more than 120,000 convenience store stores in 2018, with an industry growth rate of 19%. In other words, once all convenience stores nationwide sell drugs, at least 120,000 convenience stores will join the battle for the over-the-counter drug market.
Looking for chemical products? Let suppliers reach out to you!
2026-07-04
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Hainan to promote drug import facilitation
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
-
China to focus on building quality and efficient TCM service system in next five years
Recommend Reading
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
This week, the soda ash market in China has been operating weakly
-
August China Ammonium Sulfate Market Prices Decline
-
Palm Oil Market in December Experiences Volatile Decline
-
Canada’s Seafood Exports Escape Trump’s 35 Percent Tariff USMCA Exemption Protects Salmon and Lobster Trade
-
China's Urea Market First Rises Then Falls (6.7-6.15)